age-related disease therapy (Geron/Darwin)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameage-related disease therapy (Geron/Darwin)
Drug Alias NameWerners syndrome therapy (Geron/Darwin)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHealthy AgingDiabetes Mellitus, Type 2Cardiovascular Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeron Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb CelltechChiroscience R&D IncGeron Corp
Active IndicationsN/A
Inactive IndicationsHealthy AgingDiabetes Mellitus, Type 2Cardiovascular Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A